| 1 |
Lu Y, Yang J, Zhu J, Shu Y, Zou X, Ruan Q, Luo S, Wang Y, Wen J. Advances in the Histone Acetylation Modification in the Oral Squamous Cell Carcinoma. Journal of Oncology 2023;2023:1-11. [DOI: 10.1155/2023/4616682] [Reference Citation Analysis]
|
| 2 |
Klett-Mingo JI, Pinto-Díez C, Cambronero-Plaza J, Carrión-Marchante R, Barragán-Usero M, Pérez-Morgado MI, Rodríguez-Martín E, Toledo-Lobo MV, González VM, Martín ME. Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer. Cancers (Basel) 2022;15. [PMID: 36612223 DOI: 10.3390/cancers15010227] [Reference Citation Analysis]
|
| 3 |
Chen C, Liu J. Histone acetylation modifications: A potential targets for the diagnosis and treatment of papillary thyroid cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1053618] [Reference Citation Analysis]
|
| 4 |
Feng J, Meng X. Histone modification and histone modification-targeted anti-cancer drugs in breast cancer: Fundamentals and beyond. Front Pharmacol 2022;13:946811. [DOI: 10.3389/fphar.2022.946811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Basha NJ, Basavarajaiah SM. An insight into therapeutic efficacy of heterocycles as histone-modifying enzyme inhibitors that targets cancer epigenetic pathways. Chem Biol Drug Des 2022. [PMID: 36059065 DOI: 10.1111/cbdd.14135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Blasl AT, Schulze S, Qin C, Graf LG, Vogt R, Lammers M. Post-translational lysine ac(et)ylation in health, ageing and disease. Biol Chem 2021. [PMID: 34433238 DOI: 10.1515/hsz-2021-0139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 7 |
Gruber JJ, Rangarajan A, Chou T, Geller BS, Banuelos S, Greenhouse R, Snyder MP, Lipchik AM. An acetyl-click screening platform identifies a small molecule inhibitor of Histone Acetyltransferase 1 (HAT1) with anti-tumor activity.. [DOI: 10.1101/2021.06.25.449993] [Reference Citation Analysis]
|
| 8 |
Chen D, Wapenaar H, Dekker F. Experimental approaches toward histone acetyltransferase modulators as therapeutics. Medical Epigenetics 2021. [DOI: 10.1016/b978-0-12-823928-5.00040-2] [Reference Citation Analysis]
|
| 9 |
Sikder S, Kaypee S, Kundu TK. Regulation of epigenetic state by non-histone chromatin proteins and transcription factors: Implications in disease. J Biosci 2020;45:15. [DOI: 10.1007/s12038-019-9974-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 10 |
Poziello A, Nebbioso A, Stunnenberg HG, Martens JHA, Carafa V, Altucci L. Recent insights into Histone Acetyltransferase-1: biological function and involvement in pathogenesis. Epigenetics 2021;16:838-50. [PMID: 33016232 DOI: 10.1080/15592294.2020.1827723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 11 |
Shanmugam MK, Dharmarajan A, Warrier S, Bishayee A, Kumar AP, Sethi G, Ahn KS. Role of histone acetyltransferase inhibitors in cancer therapy. Adv Protein Chem Struct Biol 2021;125:149-91. [PMID: 33931138 DOI: 10.1016/bs.apcsb.2020.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 12 |
Bon C, Halby L, Arimondo PB. Bisubstrate inhibitors: the promise of a selective and potent chemical inhibition of epigenetic 'writers'. Epigenomics 2020;12:1479-82. [PMID: 32938211 DOI: 10.2217/epi-2020-0203] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Lockhart DEA, Stanley M, Raimi OG, Robinson DA, Boldovjakova D, Squair DR, Ferenbach AT, Fang W, van Aalten DMF. Targeting a critical step in fungal hexosamine biosynthesis. J Biol Chem 2020;295:8678-91. [PMID: 32341126 DOI: 10.1074/jbc.RA120.012985] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 14 |
Lockhart DE, Stanley M, Raimi OG, Robinson DA, Boldovjakova D, Squair DR, Ferenbach AT, Fang W, van Aalten DM. Targeting a critical step in fungal hexosamine biosynthesis.. [DOI: 10.1101/2020.01.07.896944] [Reference Citation Analysis]
|
| 15 |
Song J, Zheng YG. Bioorthogonal Reporters for Detecting and Profiling Protein Acetylation and Acylation. SLAS Discov 2020;25:148-62. [PMID: 31711353 DOI: 10.1177/2472555219887144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Hałasa M, Wawruszak A, Przybyszewska A, Jaruga A, Guz M, Kałafut J, Stepulak A, Cybulski M. H3K18Ac as a Marker of Cancer Progression and Potential Target of Anti-Cancer Therapy. Cells 2019;8:E485. [PMID: 31121824 DOI: 10.3390/cells8050485] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
|
